BioLargo Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • BioLargo's estimated annual revenue is currently $2.3M per year.(i)
  • BioLargo's estimated revenue per employee is $98,000

Employee Data

  • BioLargo has 23 Employees.(i)
  • BioLargo grew their employee count by -4% last year.

BioLargo's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Exec Vp OperationsReveal Email/Phone
3
EVP OperationsReveal Email/Phone
4
VP Technology DevelopmentReveal Email/Phone
5
Director BizDevReveal Email/Phone
6
Director Corporate DevelopmentReveal Email/Phone
7
Director Strategic Marketing and Business DevelopmentReveal Email/Phone
8
Director Corp DevelopmentReveal Email/Phone
9
Director Corporate CommunicationsReveal Email/Phone
10
Chief Science OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$212.8M10635%$65MN/A
#2
$35.6M2316%N/AN/A
#3
$45M299-4%$102.6MN/A
#4
$3.2M30-25%$21.3MN/A
#5
$34M2260%$42.9MN/A
#6
$3.6M34-28%$35MN/A
#7
$0.8M10N/AN/AN/A
#8
$12.6M90-9%N/AN/A
#9
$17.4M1240%$96.4MN/A
#10
$5.2M49-25%$75.6MN/A
Add Company

What Is BioLargo?

BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 of extensive R&D, BLGO holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BLGO has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. Several of our technologies are commercially available and are advancing as disrupters in their respective markets. See our website at www.BioLargo.com.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.3M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioLargo News

2022-04-13 - BioLargo Continues Growth Trend by Breaking Quarterly Revenue Record

WESTMINSTER, CA / ACCESSWIRE / April 20, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and...

2022-03-30 - BioLargo, Inc. (BLGO) CEO Dennis Calvert on Q4 2021 Results - Earnings Call Transcript

And welcome to the BioLargo Year End 2021 Earnings Results Conference Call. At this time, all participants have been placed on a listen-only...

2022-03-22 - BioLargo Annual Report for 2021 Highlights Active Commercial Catalysts, Expanding Partnerships, and Improved Balance Sheet

WESTMINSTER, CA / ACCESSWIRE / March 31, 2022 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.9M235%N/A
#2
$4.3M235%N/A
#3
$2.9M2310%N/A
#4
$1.7M24-35%$17M
#5
$4.5M249%N/A